PHLOW CORP

Overview

PHLOW CORP is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering CIPROFLOXACIN HYDROCHLORIDE USP; EPINEPHRINE USP; LABETALOL HYDROCHLORIDE; SUCCINYLCHOLINE CHLORIDE, USP.

API / Drug Master Files

PHLOW CORP holds 4 active (4 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• CIPROFLOXACIN HYDROCHLORIDE USPActive2024-12-23
• EPINEPHRINE USPActive2024-12-16
• SUCCINYLCHOLINE CHLORIDE, USPActive2022-12-15
• LABETALOL HYDROCHLORIDEActive2021-11-17

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to PHLOW CORP in our records. PharmaTek screens the full directory against live FDA enforcement data.